SHINIL PHARMACEUTICAL CO., LTD. financial statements, including revenue, expenses, and profit
The total revenue of 012790 for the last quarter is 21.54 B KRW, and it's 4.44% higher compared to the previous quarter. The net income of Q4 24 is 3.91 B KRW.